

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.04509116 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.91536283 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.89429582 |
| 4 | drug catabolic process (GO:0042737) | 8.59039792 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.18826885 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.18826885 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.91834567 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.91834567 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.55880519 |
| 10 | drug metabolic process (GO:0017144) | 6.09116527 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.99552045 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.99552045 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.99552045 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.97826258 |
| 15 | ethanol metabolic process (GO:0006067) | 5.93419483 |
| 16 | oxidative demethylation (GO:0070989) | 5.82687702 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.78927254 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.77206804 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.58933647 |
| 20 | urea cycle (GO:0000050) | 5.55998203 |
| 21 | urea metabolic process (GO:0019627) | 5.55998203 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.48539918 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.44250630 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.37411233 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30963351 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.23748865 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.15327670 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.15279955 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.10519535 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.09689802 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.00103408 |
| 32 | protein carboxylation (GO:0018214) | 5.00103408 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 4.99185091 |
| 34 | cysteine metabolic process (GO:0006534) | 4.98834967 |
| 35 | glucuronate metabolic process (GO:0019585) | 4.94513738 |
| 36 | uronic acid metabolic process (GO:0006063) | 4.94513738 |
| 37 | negative regulation of blood coagulation (GO:0030195) | 4.89436743 |
| 38 | negative regulation of hemostasis (GO:1900047) | 4.89436743 |
| 39 | bile acid metabolic process (GO:0008206) | 4.84908002 |
| 40 | S-adenosylmethionine metabolic process (GO:0046500) | 4.83918371 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83223613 |
| 42 | regulation of humoral immune response (GO:0002920) | 4.80074288 |
| 43 | regulation of complement activation (GO:0030449) | 4.79139318 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.76573374 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.75720541 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.70918112 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.69821524 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.58567312 |
| 49 | phospholipid efflux (GO:0033700) | 4.50371266 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.48908716 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.48908716 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.48908716 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.46723751 |
| 54 | negative regulation of coagulation (GO:0050819) | 4.44035750 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.42879982 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.39686694 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.38513222 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.38513222 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.35516474 |
| 60 | negative regulation of wound healing (GO:0061045) | 4.35328315 |
| 61 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.33336214 |
| 62 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.33336214 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 4.31934289 |
| 64 | positive regulation of hemostasis (GO:1900048) | 4.31934289 |
| 65 | homocysteine metabolic process (GO:0050667) | 4.31838329 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.31820242 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.31820242 |
| 68 | glycine metabolic process (GO:0006544) | 4.31101065 |
| 69 | alkaloid metabolic process (GO:0009820) | 4.25190913 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.24805221 |
| 71 | negative regulation of protein activation cascade (GO:2000258) | 4.22111907 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.17249573 |
| 73 | amine catabolic process (GO:0009310) | 4.14114535 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.14114535 |
| 75 | lysine metabolic process (GO:0006553) | 4.10972978 |
| 76 | lysine catabolic process (GO:0006554) | 4.10972978 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.08256590 |
| 78 | blood coagulation, intrinsic pathway (GO:0007597) | 4.05109683 |
| 79 | arginine metabolic process (GO:0006525) | 4.02371275 |
| 80 | ethanol oxidation (GO:0006069) | 4.01979334 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 3.98446749 |
| 82 | positive regulation of coagulation (GO:0050820) | 3.98233382 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.97504327 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.96887292 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.96235871 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.94774619 |
| 87 | cholesterol efflux (GO:0033344) | 3.93924506 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.89527870 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.87129134 |
| 90 | glutamate metabolic process (GO:0006536) | 3.83145371 |
| 91 | cytolysis (GO:0019835) | 3.80732644 |
| 92 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.79875147 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.78677692 |
| 94 | NAD biosynthetic process (GO:0009435) | 3.77855203 |
| 95 | cellular glucuronidation (GO:0052695) | 3.77642704 |
| 96 | fibrinolysis (GO:0042730) | 3.77158558 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.75705887 |
| 98 | regulation of apoptotic cell clearance (GO:2000425) | 3.73241987 |
| 99 | protein activation cascade (GO:0072376) | 3.71701207 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70346371 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 3.70075889 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.66690633 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.66690633 |
| 104 | complement activation (GO:0006956) | 3.66374596 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63776023 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63776023 |
| 107 | acute inflammatory response (GO:0002526) | 3.63758011 |
| 108 | aldehyde catabolic process (GO:0046185) | 3.63703566 |
| 109 | acute-phase response (GO:0006953) | 3.61108923 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60085229 |
| 111 | cofactor catabolic process (GO:0051187) | 3.58097155 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.55137434 |
| 113 | cholesterol homeostasis (GO:0042632) | 3.53519219 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.51731347 |
| 115 | organic acid catabolic process (GO:0016054) | 3.51731347 |
| 116 | intestinal cholesterol absorption (GO:0030299) | 3.50009568 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.49484145 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.49369084 |
| 119 | response to mercury ion (GO:0046689) | 3.48395463 |
| 120 | opsonization (GO:0008228) | 3.47281777 |
| 121 | regulation of lipoprotein particle clearance (GO:0010984) | 3.46518791 |
| 122 | plasma lipoprotein particle organization (GO:0071827) | 3.46225366 |
| 123 | sterol homeostasis (GO:0055092) | 3.45753081 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44892545 |
| 125 | phospholipid homeostasis (GO:0055091) | 3.42938380 |
| 126 | negative regulation of complement activation (GO:0045916) | 3.42635422 |
| 127 | regulation of plasminogen activation (GO:0010755) | 3.41993548 |
| 128 | ketone body metabolic process (GO:1902224) | 3.41563127 |
| 129 | hormone catabolic process (GO:0042447) | 3.41522364 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.40921190 |
| 131 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39536934 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.38909936 |
| 133 | regulation of bile acid biosynthetic process (GO:0070857) | 3.38867266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.41673964 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.53381194 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.47178013 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.55088941 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.87157858 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.63811504 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.31276432 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.86432096 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.16953437 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.88630174 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.38052103 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34500781 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7218548 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99431934 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83821801 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81072994 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80497003 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78665218 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77738357 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75919338 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69431363 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43696502 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39784023 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34717261 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22157941 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21430006 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19772028 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18815867 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18366963 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16413804 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15691598 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14966996 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14250067 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13264812 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11350740 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11322827 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10072505 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05723032 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02049916 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01416592 |
| 41 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01412575 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00976869 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00777498 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00187664 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99868485 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98143327 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 0.96959030 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94074963 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94021584 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93398128 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 0.92897030 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.91779509 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91765672 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 0.91571607 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90716211 |
| 56 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.90504965 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90273461 |
| 58 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89119838 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88556223 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88552644 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88159668 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.87959759 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87956725 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87592928 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84890304 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84846347 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84285936 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.84074731 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83402151 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.82656214 |
| 71 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82231370 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81868867 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.80994486 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80715424 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80510722 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79803790 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78513081 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77488270 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76804388 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76585492 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76525999 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 0.76340740 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76293746 |
| 84 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74305669 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74096115 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73156504 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73070087 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72753128 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.72583369 |
| 90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.71838389 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71521015 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71333378 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.70203822 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.70086663 |
| 95 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.69794193 |
| 96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.69645557 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69565953 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.69051260 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69034981 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68851814 |
| 101 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68137069 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.67873173 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67811035 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67609732 |
| 105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67593433 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67525878 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67414790 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.67099804 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.66444147 |
| 110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.66283433 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66274747 |
| 112 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.66113429 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65953788 |
| 114 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.65658806 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.65537236 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65485244 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64126621 |
| 118 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.63350708 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63009361 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.62885892 |
| 121 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62874915 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62389650 |
| 123 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62366060 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62085573 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61414206 |
| 126 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61412398 |
| 127 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61294598 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.61073734 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60778433 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60625805 |
| 131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.60424384 |
| 132 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.60308231 |
| 133 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60022839 |
| 134 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.59115940 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.58810161 |
| 136 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.58591038 |
| 137 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.58506426 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57733808 |
| 139 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57129577 |
| 140 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.57118695 |
| 141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57032966 |
| 142 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.56633499 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56442405 |
| 144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.56414298 |
| 145 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.56193430 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56167527 |
| 147 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.55754660 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.55467954 |
| 149 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.55388647 |
| 150 | ERA_21632823_ChIP-Seq_H3396_Human | 0.55065226 |
| 151 | P300_27268052_Chip-Seq_Bcells_Human | 0.54927282 |
| 152 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54152653 |
| 153 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.53824000 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.53288673 |
| 155 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.53170832 |
| 156 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.51532684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.35574900 |
| 2 | MP0005360_urolithiasis | 6.79817948 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.88980297 |
| 4 | MP0005365_abnormal_bile_salt | 5.75169256 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.58406678 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.78423346 |
| 7 | MP0003252_abnormal_bile_duct | 3.55152933 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.29346717 |
| 9 | MP0009840_abnormal_foam_cell | 3.13183184 |
| 10 | MP0005083_abnormal_biliary_tract | 2.71653337 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.54434244 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.46552930 |
| 13 | MP0005332_abnormal_amino_acid | 2.46501018 |
| 14 | MP0003195_calcinosis | 2.25608351 |
| 15 | MP0000609_abnormal_liver_physiology | 2.18043404 |
| 16 | MP0003868_abnormal_feces_composition | 2.04574647 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.03831570 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.89792854 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.80722605 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.79895310 |
| 21 | MP0001764_abnormal_homeostasis | 1.75625480 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56011161 |
| 23 | MP0000685_abnormal_immune_system | 1.55507036 |
| 24 | MP0002254_reproductive_system_inflammat | 1.46547762 |
| 25 | MP0009697_abnormal_copulation | 1.44655214 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.38297014 |
| 27 | MP0001661_extended_life_span | 1.35162723 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.33444046 |
| 29 | MP0003011_delayed_dark_adaptation | 1.32632912 |
| 30 | MP0000598_abnormal_liver_morphology | 1.29738611 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.26977586 |
| 32 | * MP0008469_abnormal_protein_level | 1.26947033 |
| 33 | MP0003724_increased_susceptibility_to | 1.25304344 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.24963605 |
| 35 | MP0003186_abnormal_redox_activity | 1.24404769 |
| 36 | MP0009763_increased_sensitivity_to | 1.24082978 |
| 37 | MP0009764_decreased_sensitivity_to | 1.22624915 |
| 38 | MP0005451_abnormal_body_composition | 1.18687956 |
| 39 | MP0003436_decreased_susceptibility_to | 1.17537406 |
| 40 | MP0005647_abnormal_sex_gland | 1.13812252 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.12463770 |
| 42 | * MP0009785_altered_susceptibility_to | 1.10938149 |
| 43 | MP0005671_abnormal_response_to | 1.08775324 |
| 44 | MP0009053_abnormal_anal_canal | 1.04784020 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 1.04611889 |
| 46 | MP0006082_CNS_inflammation | 0.99348591 |
| 47 | MP0003763_abnormal_thymus_physiology | 0.99137649 |
| 48 | * MP0005025_abnormal_response_to | 0.98239453 |
| 49 | MP0008872_abnormal_physiological_respon | 0.96910481 |
| 50 | MP0001800_abnormal_humoral_immune | 0.95261372 |
| 51 | MP0001853_heart_inflammation | 0.93693760 |
| 52 | MP0002282_abnormal_trachea_morphology | 0.92674354 |
| 53 | * MP0009642_abnormal_blood_homeostasis | 0.92096594 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 0.91003087 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 0.90088133 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 0.89864492 |
| 57 | MP0000604_amyloidosis | 0.88117947 |
| 58 | MP0003879_abnormal_hair_cell | 0.86539206 |
| 59 | MP0001845_abnormal_inflammatory_respons | 0.85037145 |
| 60 | MP0002249_abnormal_larynx_morphology | 0.84729803 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.84416653 |
| 62 | MP0001873_stomach_inflammation | 0.84398330 |
| 63 | MP0005395_other_phenotype | 0.82889648 |
| 64 | MP0001790_abnormal_immune_system | 0.82318495 |
| 65 | MP0005387_immune_system_phenotype | 0.82318495 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 0.81293389 |
| 67 | MP0010155_abnormal_intestine_physiology | 0.77126294 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.75128425 |
| 69 | * MP0002723_abnormal_immune_serum | 0.73557160 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.72577676 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.72273768 |
| 72 | MP0002168_other_aberrant_phenotype | 0.71996272 |
| 73 | MP0004381_abnormal_hair_follicle | 0.71423322 |
| 74 | MP0000566_synostosis | 0.71290866 |
| 75 | * MP0002419_abnormal_innate_immunity | 0.69494516 |
| 76 | MP0004947_skin_inflammation | 0.69327082 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 0.68211218 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.67787463 |
| 79 | MP0005670_abnormal_white_adipose | 0.67598628 |
| 80 | MP0005334_abnormal_fat_pad | 0.67166121 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.66172787 |
| 82 | MP0005408_hypopigmentation | 0.66121952 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.63948067 |
| 84 | MP0002971_abnormal_brown_adipose | 0.62474683 |
| 85 | MP0003075_altered_response_to | 0.62191088 |
| 86 | MP0001915_intracranial_hemorrhage | 0.61835568 |
| 87 | MP0003690_abnormal_glial_cell | 0.61239927 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.60222673 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 0.59931435 |
| 90 | MP0002132_abnormal_respiratory_system | 0.59277850 |
| 91 | MP0002722_abnormal_immune_system | 0.58932184 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.58726324 |
| 93 | MP0002396_abnormal_hematopoietic_system | 0.58384232 |
| 94 | MP0000716_abnormal_immune_system | 0.58040410 |
| 95 | * MP0002452_abnormal_antigen_presenting | 0.58006484 |
| 96 | MP0008873_increased_physiological_sensi | 0.56558484 |
| 97 | MP0002398_abnormal_bone_marrow | 0.55992509 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.55518256 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.55318617 |
| 100 | MP0004130_abnormal_muscle_cell | 0.55317617 |
| 101 | * MP0002420_abnormal_adaptive_immunity | 0.54918960 |
| 102 | * MP0001819_abnormal_immune_cell | 0.54079367 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.53818534 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.53818534 |
| 105 | MP0005535_abnormal_body_temperature | 0.53360799 |
| 106 | MP0004883_abnormal_blood_vessel | 0.52433426 |
| 107 | MP0002928_abnormal_bile_duct | 0.51137975 |
| 108 | MP0002429_abnormal_blood_cell | 0.51080786 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.51035729 |
| 110 | MP0005266_abnormal_metabolism | 0.51003668 |
| 111 | MP0000249_abnormal_blood_vessel | 0.49999024 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.49022666 |
| 113 | MP0005166_decreased_susceptibility_to | 0.48870014 |
| 114 | MP0009379_abnormal_foot_pigmentation | 0.48728848 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.48313864 |
| 116 | MP0008874_decreased_physiological_sensi | 0.46197835 |
| 117 | MP0005187_abnormal_penis_morphology | 0.45713799 |
| 118 | MP0003718_maternal_effect | 0.44641010 |
| 119 | MP0000467_abnormal_esophagus_morphology | 0.43848576 |
| 120 | MP0005023_abnormal_wound_healing | 0.43414116 |
| 121 | MP0005164_abnormal_response_to | 0.42536555 |
| 122 | MP0005448_abnormal_energy_balance | 0.41797278 |
| 123 | MP0003329_amyloid_beta_deposits | 0.39197624 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.36767049 |
| 125 | MP0005646_abnormal_pituitary_gland | 0.36696371 |
| 126 | MP0001881_abnormal_mammary_gland | 0.34389506 |
| 127 | MP0003878_abnormal_ear_physiology | 0.30456342 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.30456342 |
| 129 | MP0003953_abnormal_hormone_level | 0.27720570 |
| 130 | MP0009115_abnormal_fat_cell | 0.27078449 |
| 131 | MP0001851_eye_inflammation | 0.25792795 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.25582021 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.25412965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17306941 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.82249922 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.71241930 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30237036 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.29894391 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.07864479 |
| 7 | Xanthomatosis (HP:0000991) | 5.73490277 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.37259609 |
| 9 | Complement deficiency (HP:0004431) | 4.97917645 |
| 10 | Joint hemorrhage (HP:0005261) | 4.75384830 |
| 11 | Hyperammonemia (HP:0001987) | 4.39140309 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.38065277 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35136334 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09095010 |
| 15 | Epidermoid cyst (HP:0200040) | 4.00982733 |
| 16 | Nephritis (HP:0000123) | 3.99563273 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 3.98592329 |
| 18 | Fat malabsorption (HP:0002630) | 3.88028942 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84773281 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.84724487 |
| 21 | Ketosis (HP:0001946) | 3.83849202 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.82980419 |
| 23 | Hyperglycinemia (HP:0002154) | 3.78436250 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74421308 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.67856778 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.64646426 |
| 27 | Abnormality of complement system (HP:0005339) | 3.56778785 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.42876141 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42538955 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40012297 |
| 31 | Spontaneous abortion (HP:0005268) | 3.34243814 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.33961203 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33961203 |
| 34 | Hyperglycinuria (HP:0003108) | 3.33478806 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.32818954 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.29208180 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21350352 |
| 38 | Gingival bleeding (HP:0000225) | 3.09223207 |
| 39 | Steatorrhea (HP:0002570) | 3.02331241 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.86627050 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.85717261 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85568685 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.76543747 |
| 44 | Neonatal hypoglycemia (HP:0001998) | 2.75088814 |
| 45 | Acanthocytosis (HP:0001927) | 2.73155481 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69500866 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.69018870 |
| 48 | Myocardial infarction (HP:0001658) | 2.65519349 |
| 49 | Menorrhagia (HP:0000132) | 2.64170368 |
| 50 | Fair hair (HP:0002286) | 2.63677087 |
| 51 | Metabolic acidosis (HP:0001942) | 2.58571059 |
| 52 | Thrombophlebitis (HP:0004418) | 2.54167306 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.49709175 |
| 54 | Rickets (HP:0002748) | 2.48888400 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46831986 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.46831986 |
| 57 | Ketoacidosis (HP:0001993) | 2.44623489 |
| 58 | Spastic diplegia (HP:0001264) | 2.42740742 |
| 59 | Epistaxis (HP:0000421) | 2.42081257 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.41142374 |
| 61 | Lethargy (HP:0001254) | 2.34442259 |
| 62 | Neonatal onset (HP:0003623) | 2.24923321 |
| 63 | Skin nodule (HP:0200036) | 2.23558395 |
| 64 | Mitral stenosis (HP:0001718) | 2.22377998 |
| 65 | Pulmonary embolism (HP:0002204) | 2.22231192 |
| 66 | Amyloidosis (HP:0011034) | 2.21540509 |
| 67 | Esophageal varix (HP:0002040) | 2.19415746 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.18716369 |
| 69 | Pancreatitis (HP:0001733) | 2.18031847 |
| 70 | Vascular calcification (HP:0004934) | 2.16749257 |
| 71 | Glomerulonephritis (HP:0000099) | 2.16615016 |
| 72 | Gangrene (HP:0100758) | 2.15869115 |
| 73 | Cholelithiasis (HP:0001081) | 2.14942695 |
| 74 | Joint swelling (HP:0001386) | 2.14016517 |
| 75 | Poikilocytosis (HP:0004447) | 2.13612706 |
| 76 | Irritability (HP:0000737) | 2.12888385 |
| 77 | Osteomalacia (HP:0002749) | 2.12154964 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.07876474 |
| 79 | Cerebral edema (HP:0002181) | 2.06363616 |
| 80 | Microcytic anemia (HP:0001935) | 2.04817510 |
| 81 | Elevated hepatic transaminases (HP:0002910) | 2.04203312 |
| 82 | Gout (HP:0001997) | 2.04108396 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.03725475 |
| 84 | Purpura (HP:0000979) | 2.01355759 |
| 85 | Late onset (HP:0003584) | 2.01010133 |
| 86 | Brushfield spots (HP:0001088) | 1.98479961 |
| 87 | Renal cortical cysts (HP:0000803) | 1.98177662 |
| 88 | Hypoglycemic seizures (HP:0002173) | 1.97933288 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 1.97004942 |
| 90 | Cholecystitis (HP:0001082) | 1.94191829 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 1.94191829 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92801980 |
| 93 | Opisthotonus (HP:0002179) | 1.92374862 |
| 94 | Abnormal platelet volume (HP:0011876) | 1.91463570 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.90638615 |
| 96 | Increased mean platelet volume (HP:0011877) | 1.90229322 |
| 97 | Malnutrition (HP:0004395) | 1.89299980 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 1.86686966 |
| 99 | Cardiovascular calcification (HP:0011915) | 1.86188633 |
| 100 | Hypertriglyceridemia (HP:0002155) | 1.84657846 |
| 101 | Vomiting (HP:0002013) | 1.83283444 |
| 102 | Abnormal platelet function (HP:0011869) | 1.82623523 |
| 103 | Impaired platelet aggregation (HP:0003540) | 1.82623523 |
| 104 | Sensorimotor neuropathy (HP:0007141) | 1.82087676 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.82069588 |
| 106 | Enlarged kidneys (HP:0000105) | 1.80878214 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.80376878 |
| 108 | Hyperphosphaturia (HP:0003109) | 1.80304660 |
| 109 | Increased serum ferritin (HP:0003281) | 1.78342595 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 1.77536105 |
| 111 | Cerebral palsy (HP:0100021) | 1.75685461 |
| 112 | Bifid scrotum (HP:0000048) | 1.72526252 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.71480945 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.71480945 |
| 115 | Hypochromic anemia (HP:0001931) | 1.66435215 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.66418038 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.65846955 |
| 118 | Reticulocytosis (HP:0001923) | 1.65118011 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.65007848 |
| 120 | Arthropathy (HP:0003040) | 1.64665716 |
| 121 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64522396 |
| 122 | Atrioventricular block (HP:0001678) | 1.56282564 |
| 123 | Blue irides (HP:0000635) | 1.55156000 |
| 124 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.55145182 |
| 125 | Glycosuria (HP:0003076) | 1.54560382 |
| 126 | Abnormality of urine glucose concentration (HP:0011016) | 1.54560382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.36659279 |
| 2 | FGFR4 | 4.36795614 |
| 3 | ERN1 | 3.63286809 |
| 4 | MAP4K1 | 3.24683998 |
| 5 | SIK1 | 2.90371273 |
| 6 | FLT3 | 2.87178149 |
| 7 | TAOK3 | 2.49387364 |
| 8 | TYK2 | 2.44968564 |
| 9 | TXK | 2.30273244 |
| 10 | PIK3CA | 2.19571282 |
| 11 | TBK1 | 2.10038362 |
| 12 | PKN2 | 2.07224930 |
| 13 | KIT | 2.07067838 |
| 14 | IKBKE | 2.06881093 |
| 15 | KDR | 1.94718854 |
| 16 | JAK3 | 1.93052059 |
| 17 | RIPK1 | 1.81427200 |
| 18 | ZAP70 | 1.79331313 |
| 19 | MAPK11 | 1.74217133 |
| 20 | GRK6 | 1.71806792 |
| 21 | MAP3K14 | 1.67096274 |
| 22 | PRPF4B | 1.63197277 |
| 23 | PIK3CG | 1.62438770 |
| 24 | BTK | 1.59717733 |
| 25 | MAP2K3 | 1.59530282 |
| 26 | JAK1 | 1.52696992 |
| 27 | CSF1R | 1.47463438 |
| 28 | SCYL2 | 1.46316641 |
| 29 | NME2 | 1.44135344 |
| 30 | NLK | 1.42739984 |
| 31 | TRIB3 | 1.39573444 |
| 32 | TIE1 | 1.39359196 |
| 33 | EEF2K | 1.36722600 |
| 34 | ERBB4 | 1.35727434 |
| 35 | TEC | 1.34993682 |
| 36 | TGFBR2 | 1.29071492 |
| 37 | SMG1 | 1.27638505 |
| 38 | TGFBR1 | 1.27025677 |
| 39 | JAK2 | 1.23878513 |
| 40 | MAP3K10 | 1.23810984 |
| 41 | INSRR | 1.22641426 |
| 42 | ITK | 1.18248276 |
| 43 | MAP3K7 | 1.16161354 |
| 44 | PTK6 | 1.13982171 |
| 45 | TAOK2 | 1.12015112 |
| 46 | NTRK3 | 1.08396830 |
| 47 | MUSK | 1.08117514 |
| 48 | FGFR3 | 1.04730492 |
| 49 | SYK | 1.04556393 |
| 50 | MAP2K6 | 1.03752556 |
| 51 | NEK9 | 1.01343457 |
| 52 | PRKCG | 0.98315398 |
| 53 | MAP2K4 | 0.98001754 |
| 54 | PDPK1 | 0.95136587 |
| 55 | MAP3K13 | 0.95102695 |
| 56 | EPHA3 | 0.94476296 |
| 57 | STK16 | 0.90546391 |
| 58 | EPHB1 | 0.90200454 |
| 59 | MAPK4 | 0.89900727 |
| 60 | IKBKB | 0.89579608 |
| 61 | LCK | 0.88651940 |
| 62 | CSK | 0.87157650 |
| 63 | MAP2K2 | 0.86681952 |
| 64 | MAP3K11 | 0.84725647 |
| 65 | IRAK4 | 0.79452214 |
| 66 | ACVR1B | 0.79239622 |
| 67 | FER | 0.78414748 |
| 68 | IRAK3 | 0.73400684 |
| 69 | PRKAA2 | 0.73209621 |
| 70 | PRKCZ | 0.72483580 |
| 71 | MAPK12 | 0.71055860 |
| 72 | RET | 0.70420051 |
| 73 | LRRK2 | 0.70234717 |
| 74 | DYRK1B | 0.69416803 |
| 75 | LYN | 0.68153311 |
| 76 | PRKACA | 0.66385305 |
| 77 | MST1R | 0.66225994 |
| 78 | PRKCQ | 0.66106689 |
| 79 | CDK6 | 0.65358301 |
| 80 | BLK | 0.63520035 |
| 81 | GRK1 | 0.61799209 |
| 82 | STK10 | 0.59706332 |
| 83 | PRKG1 | 0.58952438 |
| 84 | CDK4 | 0.58926993 |
| 85 | CSNK1D | 0.57584327 |
| 86 | HCK | 0.56841325 |
| 87 | RPS6KB2 | 0.55533833 |
| 88 | ADRBK2 | 0.55354296 |
| 89 | TRPM7 | 0.55252952 |
| 90 | CHUK | 0.54952388 |
| 91 | PINK1 | 0.53606079 |
| 92 | TESK2 | 0.53042150 |
| 93 | ABL2 | 0.51997470 |
| 94 | EPHA2 | 0.51195047 |
| 95 | PRKCA | 0.50953915 |
| 96 | PIM1 | 0.50152093 |
| 97 | ERBB2 | 0.48958787 |
| 98 | IRAK1 | 0.48022638 |
| 99 | TNK2 | 0.46951180 |
| 100 | PRKAA1 | 0.45469483 |
| 101 | PIM2 | 0.43666661 |
| 102 | DYRK3 | 0.42273809 |
| 103 | MAPK15 | 0.42156081 |
| 104 | FRK | 0.42037594 |
| 105 | SRC | 0.41515471 |
| 106 | IGF1R | 0.40812457 |
| 107 | MAPKAPK5 | 0.39936628 |
| 108 | CSNK2A1 | 0.39330422 |
| 109 | MAPK7 | 0.38667258 |
| 110 | MAPKAPK3 | 0.38403038 |
| 111 | RPS6KA4 | 0.38056702 |
| 112 | RPS6KB1 | 0.37992238 |
| 113 | PDK2 | 0.36700862 |
| 114 | PRKCB | 0.36107311 |
| 115 | CAMKK1 | 0.36074052 |
| 116 | RPS6KA3 | 0.36065387 |
| 117 | MAP3K3 | 0.35804286 |
| 118 | MATK | 0.35674909 |
| 119 | DYRK1A | 0.35474171 |
| 120 | ICK | 0.35243954 |
| 121 | PDK1 | 0.34892407 |
| 122 | PRKACG | 0.34623863 |
| 123 | MAPK3 | 0.34197371 |
| 124 | PRKG2 | 0.33863018 |
| 125 | EIF2AK3 | 0.33047544 |
| 126 | MTOR | 0.32749919 |
| 127 | CSNK2A2 | 0.31831721 |
| 128 | NEK6 | 0.31201903 |
| 129 | CSNK1G1 | 0.30508816 |
| 130 | FGFR2 | 0.30465302 |
| 131 | MYLK | 0.26247265 |
| 132 | DAPK2 | 0.24978602 |
| 133 | MAP3K1 | 0.24190742 |
| 134 | EGFR | 0.23625076 |
| 135 | ABL1 | 0.23288227 |
| 136 | PRKCH | 0.23251537 |
| 137 | MAP3K12 | 0.22654715 |
| 138 | FES | 0.22421396 |
| 139 | CAMK2G | 0.21331228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.70546652 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47635954 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45562279 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34322447 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03756464 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.88901291 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66293181 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61389760 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47959552 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46422763 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44921057 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30527341 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26134588 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.08670278 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99320543 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96268986 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93185396 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91223780 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.90568781 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89473846 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83158785 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81838609 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81154363 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79079724 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75754168 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71661759 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67375286 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65952806 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62609160 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61883009 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59734484 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58311369 |
| 33 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43586377 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43238021 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37888092 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36660905 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.32996783 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.30434012 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30389161 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26973686 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26295324 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26216782 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20780025 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18889771 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18520093 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17761957 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10823611 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09794122 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09348536 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03965339 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03683353 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02625792 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96932738 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95498886 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94612325 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84468792 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83477362 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78543778 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74018839 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70680173 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.70308935 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61321201 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59526532 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58976431 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57369457 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53938675 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.44542802 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43323482 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31295658 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30229733 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27512383 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25612424 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.24465089 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24277516 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24006159 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23844235 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23133788 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22989704 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.22358681 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19690577 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17475802 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16464771 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14070544 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12976540 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.08410394 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07522800 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.06566674 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.05500759 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.04231983 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.02411463 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.00890273 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00030140 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2832939 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2788528 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.2607137 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2473678 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2239928 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1927676 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1925218 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1902183 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1459769 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1162047 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | -0.0975757 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0887791 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | -0.0827771 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0757692 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0742771 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | -0.0708949 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0695920 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0639577 |
| 111 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | -0.0570007 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0569671 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0561151 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0529192 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0492088 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0361265 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | -0.0236479 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | -0.0146803 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0116809 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0011724 |

